rs9513851

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_052867.4(NALCN):​c.3210C>T​(p.Asn1070Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0645 in 1,611,716 control chromosomes in the GnomAD database, including 3,776 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.063 ( 332 hom., cov: 32)
Exomes 𝑓: 0.065 ( 3444 hom. )

Consequence

NALCN
NM_052867.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 1.39

Publications

11 publications found
Variant links:
Genes affected
NALCN (HGNC:19082): (sodium leak channel, non-selective) This gene encodes a voltage-independent, nonselective cation channel which belongs to a family of voltage-gated sodium and calcium channels that regulates the resting membrane potential and excitability of neurons. This family is expressed throughout the nervous system and conducts a persistent sodium leak current that contributes to tonic neuronal excitability. The encoded protein forms a channelosome complex that includes G-protein-coupled receptors, UNC-79, UNC-80, NCA localization factor-1, and src family tyrosine kinases. Naturally occurring mutations in this gene are associated with infantile neuroaxonal dystrophy, infantile hypotonia with psychomotor retardation and characteristic facies (IHPRF) syndrome, and congenital contractures of the limbs and face with hypotonia and developmental delay (CLIFAHDD) syndrome. A knockout of the orthologous gene in mice results in paralysis with a severely disrupted respiratory rhythm, and lethality within 24 hours after birth. [provided by RefSeq, Apr 2017]
NALCN Gene-Disease associations (from GenCC):
  • congenital contractures of the limbs and face, hypotonia, and developmental delay
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • hypotonia, infantile, with psychomotor retardation and characteristic facies 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • digitotalar dysmorphism
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Freeman-Sheldon syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Sheldon-hall syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hypotonia, infantile, with psychomotor retardation and characteristic facies
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • temporal lobe epilepsy
    Inheritance: AD Classification: LIMITED Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 13-101095633-G-A is Benign according to our data. Variant chr13-101095633-G-A is described in ClinVar as Benign. ClinVar VariationId is 262259.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.38 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.104 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NALCNNM_052867.4 linkc.3210C>T p.Asn1070Asn synonymous_variant Exon 28 of 44 ENST00000251127.11 NP_443099.1 Q8IZF0-1A0A024RE05

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NALCNENST00000251127.11 linkc.3210C>T p.Asn1070Asn synonymous_variant Exon 28 of 44 1 NM_052867.4 ENSP00000251127.6 Q8IZF0-1

Frequencies

GnomAD3 genomes
AF:
0.0633
AC:
9608
AN:
151756
Hom.:
330
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0742
Gnomad AMI
AF:
0.0407
Gnomad AMR
AF:
0.0489
Gnomad ASJ
AF:
0.100
Gnomad EAS
AF:
0.0340
Gnomad SAS
AF:
0.112
Gnomad FIN
AF:
0.0384
Gnomad MID
AF:
0.0981
Gnomad NFE
AF:
0.0612
Gnomad OTH
AF:
0.0535
GnomAD2 exomes
AF:
0.0627
AC:
15678
AN:
249948
AF XY:
0.0670
show subpopulations
Gnomad AFR exome
AF:
0.0706
Gnomad AMR exome
AF:
0.0304
Gnomad ASJ exome
AF:
0.0963
Gnomad EAS exome
AF:
0.0375
Gnomad FIN exome
AF:
0.0445
Gnomad NFE exome
AF:
0.0624
Gnomad OTH exome
AF:
0.0653
GnomAD4 exome
AF:
0.0647
AC:
94412
AN:
1459842
Hom.:
3444
Cov.:
31
AF XY:
0.0666
AC XY:
48389
AN XY:
726226
show subpopulations
African (AFR)
AF:
0.0713
AC:
2382
AN:
33386
American (AMR)
AF:
0.0317
AC:
1413
AN:
44624
Ashkenazi Jewish (ASJ)
AF:
0.0945
AC:
2465
AN:
26088
East Asian (EAS)
AF:
0.0334
AC:
1324
AN:
39634
South Asian (SAS)
AF:
0.114
AC:
9760
AN:
85954
European-Finnish (FIN)
AF:
0.0473
AC:
2525
AN:
53348
Middle Eastern (MID)
AF:
0.0989
AC:
569
AN:
5756
European-Non Finnish (NFE)
AF:
0.0628
AC:
69799
AN:
1110756
Other (OTH)
AF:
0.0692
AC:
4175
AN:
60296
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.437
Heterozygous variant carriers
0
4415
8830
13244
17659
22074
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2684
5368
8052
10736
13420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0633
AC:
9621
AN:
151874
Hom.:
332
Cov.:
32
AF XY:
0.0636
AC XY:
4719
AN XY:
74242
show subpopulations
African (AFR)
AF:
0.0742
AC:
3074
AN:
41404
American (AMR)
AF:
0.0489
AC:
744
AN:
15230
Ashkenazi Jewish (ASJ)
AF:
0.100
AC:
347
AN:
3468
East Asian (EAS)
AF:
0.0345
AC:
178
AN:
5164
South Asian (SAS)
AF:
0.112
AC:
538
AN:
4812
European-Finnish (FIN)
AF:
0.0384
AC:
405
AN:
10546
Middle Eastern (MID)
AF:
0.102
AC:
30
AN:
294
European-Non Finnish (NFE)
AF:
0.0612
AC:
4157
AN:
67948
Other (OTH)
AF:
0.0529
AC:
111
AN:
2098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
459
917
1376
1834
2293
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
118
236
354
472
590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0651
Hom.:
367
Bravo
AF:
0.0626
Asia WGS
AF:
0.0660
AC:
229
AN:
3478
EpiCase
AF:
0.0631
EpiControl
AF:
0.0644

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jul 15, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.48
CADD
Benign
4.7
DANN
Benign
0.68
PhyloP100
1.4
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9513851; hg19: chr13-101747984; COSMIC: COSV51925834; API